Meiji Holdings Reports Mixed Earnings Amid Sales Growth

Meiji Holdings Co ( (MEJHF) ) has released its Q3 earnings. Here is a breakdown of the information Meiji Holdings Co presented to its investors.

Meiji Holdings Co., Ltd. is a prominent Japanese company listed on the Tokyo Stock Exchange, primarily engaged in the food and pharmaceutical industries, known for its diverse product range and innovative solutions. In its latest earnings report, Meiji Holdings reported strong net sales growth of 5% for the first nine months of the fiscal year ending March 2025, reaching JPY 875.026 billion. However, despite the increase in sales, the company experienced declines in both operating and ordinary profits, down by 4.7% and 4.8% respectively, compared to the previous year.

Key performance highlights include significant sales growth in the Chocolate business and increased operating profit in the Dairy business, driven by price adjustments and improved production efficiencies. The Pharmaceutical segment saw a notable increase in net sales, particularly in the domestic and overseas markets, although operating profit in this segment declined due to valuation losses on a next-generation COVID-19 vaccine.

The company’s balance sheet shows total assets of JPY 1,217.395 billion, with a slight increase in liabilities. Cash flow from operating activities decreased significantly, highlighting challenges in trade payables and inventory management. Meiji Holdings maintains its forecast for the fiscal year ending March 2025, with expected net sales of JPY 1,159 billion and a slight increase in operating profit.

Looking forward, Meiji Holdings is focused on executing its Medium-Term Business Plan to drive growth and improve profitability across its segments. The company remains committed to strengthening its market position through strategic initiatives and responding to market dynamics effectively.